|

AGuIX Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Dana-Farber Cancer Institute1

Indications

  • Ductal Adenocarcinoma of the Pancreas1
  • Advanced Pancreatic Adenocarcinoma1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1
  • Unresectable Pancreatic Cancer1

Boston, Massachusetts1 trial

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Brigham and Women's Hospital

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.